Live feed
·
PRReleasevia Quantisnow
Brainstorm Cell Therapeutics Inc. logo

BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCLI (Brainstorm Cell Therapeutics Inc.) and more on Quantisnow.